DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
1496
IOPHENDYLATE
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IOPHENDYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
6V3I57K9UL
Molecule Type:
Small molecule
Molecular Formula:
C19H29IO2
Molecular Weight:
416.34
AlogP:
6.08
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
11.0
Source:
IOTHALAMATE MEGLUMINE; IOTHALAMATE SODIUM
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
IOTHALAMATE MEGLUMINE; IOTHALAMATE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOTHALAMATE SODIUM I-125
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IOTHALAMATE SODIUM I-125
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IPODATE CALCIUM
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
IPODATE CALCIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
50S7W5M9ZZ
Molecule Type:
Small molecule
Molecular Formula:
C24H24CaI6N4O4
Molecular Weight:
1233.98
AlogP:
3.74
PSA:
52.9
HBD:
1.0
HBA:
#RotB:
5.0
Source:
IRBESARTAN; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
IRBESARTAN; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRBESARTAN: HYDROCHLOROTHIAZIDE
4
Unknown
Approved
OTHER
ORAL
Unknown
Unknown
IRBESARTAN: HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRON DEXTRAN
4
Unknown
Approved
OTHER
INJECTION
Pregnancy; Anemia; Anemia, Iron-Deficiency; Folic Acid Deficiency
Unknown
IRON DEXTRAN
×
Maximum Phase:
4
First Approval:
None
UNII:
95HR524N2M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISONIAZID; PYRAZINAMIDE; RIFAMPIN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ISONIAZID; PYRAZINAMIDE; RIFAMPIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISONIAZID; RIFAMPIN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ISONIAZID; RIFAMPIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISOPROTERENOL HYDROCHLORIDE; PHENYLEPHRINE BITARTRATE
4
Combination
Approved
OTHER
INHALATION
Unknown
Unknown
ISOPROTERENOL HYDROCHLORIDE; PHENYLEPHRINE BITARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KRYPTON, KR-81M
4
Small molecule
Approved
OTHER
INHALATION
Unknown
Unknown
KRYPTON, KR-81M
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LACOSAMIDE
4
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
INTRAVENOUS; ORAL
Unknown
Unknown
LACOSAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
4
Unknown
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; NEVIRAPINE; STAVUDINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; NEVIRAPINE; STAVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
Lamivudine; Nevirapine; Zidovudine
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Lamivudine; Nevirapine; Zidovudine
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
4
Combination
Approved
OTHER
ORAL; ORAL SUSPENSION
Unknown
Unknown
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; STAVUDINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; STAVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; STAVUDINE; NEVIRAPINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; STAVUDINE; NEVIRAPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; TENOFOVIR
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; TENOFOVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; ZIDOVUDINE
4
Combination
Approved
IMMUNE SYSTEM; OTHER
ORAL; ORAL SUSPENSION
Unknown
Unknown
LAMIVUDINE; ZIDOVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; ZIDOVUDINE; ABACAVIR
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; ZIDOVUDINE; ABACAVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE;ZIDOVUDINE;EFAVIRENZ
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE;ZIDOVUDINE;EFAVIRENZ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LANSOPRAZOLE; NAPROXEN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LANSOPRAZOLE; NAPROXEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABACAVIR;LAMIVUDINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ABACAVIR;LAMIVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOFLOXACIN; DEXTROSE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
LEVOFLOXACIN; DEXTROSE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOFLOXACIN; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
LEVOFLOXACIN; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVONORDEFRIN; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
LEVONORDEFRIN; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
36
37
38
39
40
41
42
43
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA